Kristine Aasebø1, Jarle Bruun2, Christian H Bergsland2,3, Luís Nunes4, Geir Egil Eide5,6, Per Pfeiffer7, Olav Dahl8,9, Bengt Glimelius4, Ragnhild A Lothe2,3, Halfdan Sorbye8,9. 1. Department of Clinical Science, University of Bergen, Bergen, Norway. kristine.aasebo@helse-bergen.no. 2. Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. 3. Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. 4. Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. 5. Department of Global Public Health and Primary Care, Lifestyle Epidemiology Group, University of Bergen, Bergen, Norway. 6. Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway. 7. Department of Oncology, Odense University Hospital, Odense, Denmark. 8. Department of Clinical Science, University of Bergen, Bergen, Norway. 9. Department of Oncology, Haukeland University Hospital, Bergen, Norway.
Abstract
BACKGROUND: Tumour-infiltrating CD3, CD8 lymphocytes and CD68 macrophages are associated with favourable prognosis in localised colorectal cancer, but the effect in metastatic colorectal cancer (mCRC) is not established. METHODS: A Scandinavian population-based cohort of non-resectable mCRC patients was studied. Tissue microarrays (n = 460) were stained with CD3, CD8 and CD68 using fluorescence-based multiplex immunohistochemistry. Associations with clinicopathological variables, overall survival (OS) and progression-free survival were estimated. RESULTS: Two-thirds of microsatellite instable (MSI) and one-fourth of microsatellite stable (MSS) tumours displayed the highest quartile density of CD8. For CD3 high vs low cases, median OS was 20 vs 16 months (HR: 0.76, 95% CI: 0.59, 0.76, p = 0.025) with 3-year OS of 27 vs 13%. For CD68 high vs low cases, median OS was 23 vs 15 months (HR: 0.69, 95% CI: 0.54, 0.88, p = 0.003) with 3-year OS of 28 vs 12%. MSI, BRAF mutation and CDX2 loss were negative prognostic markers independent of tumour immune infiltration. CONCLUSIONS: In mCRC, high lymphocyte infiltration was found in proportions of MSI and MSS tumours-potential subgroups of immunotherapy response. Tumour-infiltrating CD3 lymphocytes and CD68 macrophages were associated with median and long-term survival. MSI was a significant negative prognostic marker despite high immunogenicity.
BACKGROUND: Tumour-infiltrating CD3, CD8 lymphocytes and CD68 macrophages are associated with favourable prognosis in localised colorectal cancer, but the effect in metastatic colorectal cancer (mCRC) is not established. METHODS: A Scandinavian population-based cohort of non-resectable mCRC patients was studied. Tissue microarrays (n = 460) were stained with CD3, CD8 and CD68 using fluorescence-based multiplex immunohistochemistry. Associations with clinicopathological variables, overall survival (OS) and progression-free survival were estimated. RESULTS: Two-thirds of microsatellite instable (MSI) and one-fourth of microsatellite stable (MSS) tumours displayed the highest quartile density of CD8. For CD3 high vs low cases, median OS was 20 vs 16 months (HR: 0.76, 95% CI: 0.59, 0.76, p = 0.025) with 3-year OS of 27 vs 13%. For CD68 high vs low cases, median OS was 23 vs 15 months (HR: 0.69, 95% CI: 0.54, 0.88, p = 0.003) with 3-year OS of 28 vs 12%. MSI, BRAF mutation and CDX2 loss were negative prognostic markers independent of tumour immune infiltration. CONCLUSIONS: In mCRC, high lymphocyte infiltration was found in proportions of MSI and MSS tumours-potential subgroups of immunotherapy response. Tumour-infiltrating CD3 lymphocytes and CD68 macrophages were associated with median and long-term survival. MSI was a significant negative prognostic marker despite high immunogenicity.
Authors: Thierry André; Kai-Keen Shiu; Tae Won Kim; Benny Vittrup Jensen; Lars Henrik Jensen; Cornelis Punt; Denis Smith; Rocio Garcia-Carbonero; Manuel Benavides; Peter Gibbs; Christelle de la Fouchardiere; Fernando Rivera; Elena Elez; Johanna Bendell; Dung T Le; Takayuki Yoshino; Eric Van Cutsem; Ping Yang; Mohammed Z H Farooqui; Patricia Marinello; Luis A Diaz Journal: N Engl J Med Date: 2020-12-03 Impact factor: 91.245
Authors: Dung T Le; Jennifer N Uram; Hao Wang; Bjarne R Bartlett; Holly Kemberling; Aleksandra D Eyring; Andrew D Skora; Brandon S Luber; Nilofer S Azad; Dan Laheru; Barbara Biedrzycki; Ross C Donehower; Atif Zaheer; George A Fisher; Todd S Crocenzi; James J Lee; Steven M Duffy; Richard M Goldberg; Albert de la Chapelle; Minori Koshiji; Feriyl Bhaijee; Thomas Huebner; Ralph H Hruban; Laura D Wood; Nathan Cuka; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; Shibin Zhou; Toby C Cornish; Janis M Taube; Robert A Anders; James R Eshleman; Bert Vogelstein; Luis A Diaz Journal: N Engl J Med Date: 2015-05-30 Impact factor: 91.245
Authors: Nicolas J Llosa; Michael Cruise; Ada Tam; Elizabeth C Wicks; Elizabeth M Hechenbleikner; Janis M Taube; Richard L Blosser; Hongni Fan; Hao Wang; Brandon S Luber; Ming Zhang; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Cynthia L Sears; Robert A Anders; Drew M Pardoll; Franck Housseau Journal: Cancer Discov Date: 2014-10-30 Impact factor: 39.397
Authors: Bernhard Mlecnik; Carlo Bifulco; Gabriela Bindea; Florence Marliot; Alessandro Lugli; J Jack Lee; Inti Zlobec; Tilman T Rau; Martin D Berger; Iris D Nagtegaal; Elisa Vink-Börger; Arndt Hartmann; Carol Geppert; Julie Kolwelter; Susanne Merkel; Robert Grützmann; Marc Van den Eynde; Anne Jouret-Mourin; Alex Kartheuser; Daniel Léonard; Christophe Remue; Julia Y Wang; Prashant Bavi; Michael H A Roehrl; Pamela S Ohashi; Linh T Nguyen; SeongJun Han; Heather L MacGregor; Sara Hafezi-Bakhtiari; Bradly G Wouters; Giuseppe V Masucci; Emilia K Andersson; Eva Zavadova; Michal Vocka; Jan Spacek; Lubos Petruzelka; Bohuslav Konopasek; Pavel Dundr; Helena Skalova; Kristyna Nemejcova; Gerardo Botti; Fabiana Tatangelo; Paolo Delrio; Gennaro Ciliberto; Michele Maio; Luigi Laghi; Fabio Grizzi; Tessa Fredriksen; Bénédicte Buttard; Lucie Lafontaine; Daniela Bruni; Anastasia Lanzi; Carine El Sissy; Nacilla Haicheur; Amos Kirilovsky; Anne Berger; Christine Lagorce; Christopher Paustian; Carmen Ballesteros-Merino; Jeroen Dijkstra; Carlijn van de Water; Shannon van Lent-van Vliet; Nikki Knijn; Ana-Maria Muşină; Dragos-Viorel Scripcariu; Boryana Popivanova; Mingli Xu; Tomonobu Fujita; Shoichi Hazama; Nobuaki Suzuki; Hiroaki Nagano; Kiyotaka Okuno; Toshihiko Torigoe; Noriyuki Sato; Tomohisa Furuhata; Ichiro Takemasa; Kyogo Itoh; Prabhu S Patel; Hemangini H Vora; Birva Shah; Jayendrakumar B Patel; Kruti N Rajvik; Shashank J Pandya; Shilin N Shukla; Yili Wang; Guanjun Zhang; Yutaka Kawakami; Francesco M Marincola; Paolo A Ascierto; Bernard A Fox; Franck Pagès; Jérôme Galon Journal: J Clin Oncol Date: 2020-09-08 Impact factor: 44.544
Authors: R Dienstmann; M J Mason; F A Sinicrope; A I Phipps; S Tejpar; A Nesbakken; S A Danielsen; A Sveen; D D Buchanan; M Clendenning; C Rosty; B Bot; S R Alberts; J Milburn Jessup; R A Lothe; M Delorenzi; P A Newcomb; D Sargent; J Guinney Journal: Ann Oncol Date: 2017-05-01 Impact factor: 32.976
Authors: G Emerens Wensink; Marloes A G Elferink; Anne M May; Linda Mol; Patricia A H Hamers; Sandra D Bakker; Geert-Jan Creemers; Jan Willem B de Groot; Gerty J de Klerk; Brigitte C M Haberkorn; Annebeth W Haringhuizen; Ronald Hoekstra; J Cornelis B Hunting; Emile D Kerver; Danielle Mathijssen-van Stein; Marco B Polée; Johannes F M Pruijt; Patricia Quarles van Ufford-Mannesse; Sandra Radema; Ronald C Rietbroek; Lieke H J Simkens; Bea C Tanis; Daan Ten Bokkel Huinink; Manuel L R Tjin-A-Ton; Cathrien S Tromp-van Driel; Monique M Troost; Agnes J van de Wouw; Franchette W P J van den Berkmortel; Anke J M van der Pas; Ankie M T van der Velden; Marjan A van Dijk; Joyce M van Dodewaard-de Jong; Edith B van Druten; Theo van Voorthuizen; Gerrit Jan Veldhuis; Henk M W Verheul; Hanneke J H M J Vestjens; Jeroen Vincent; Onno W Kranenburg; Cornelis J A Punt; Geraldine R Vink; Jeanine M L Roodhart; Miriam Koopman Journal: Br J Cancer Date: 2020-10-13 Impact factor: 7.640
Authors: Rosemary Millen; Shona Hendry; Vignesh Narasimhan; Rebecca Abbott; Matthew Croxford; Peter Gibbs; Jeanne Tie; Hui-Li Wong; Ian Jones; Suzanne Kosmider; David Byrne; John Zalcberg; Stephen Fox; Jayesh Desai; Kumar Visvanathan; Robert G Ramsay; Ben Tran Journal: Clin Transl Immunology Date: 2020-07-17